Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | ORBIMED ADVISORS LLC | Director | Buy (P) | 625K | $10.0M |
| Aug 10, 2026 | GORDON CARL L | Director | Buy (P) | 625K | $10.0M |
| Aug 10, 2026 | Keyes Jason A | Chief Financial Officer | Buy (P) | 700 | $11K |
| Aug 10, 2026 | Liptak Vincent Paul | General Counsel | Buy (P) | 2K | $35K |
| Aug 10, 2026 | Schmid John P. | Director | Buy (P) | 6K | $96K |
| Aug 10, 2026 | Chen Bihua | Director, 10% Owner | Buy (P) | 313K | $5.0M |
| Aug 7, 2026 | Liptak Vincent Paul | General Counsel | Buy (P) | 3K | $40K |
| Aug 12, 2010 | Prager Gary | Insider | Sell (S) | 250K | $3K |
| Aug 12, 2010 | Prager Brittany | Director | Sell (S) | 250K | $3K |
Connected entities for BlossomHill Therapeutics, Inc.
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/BLSM/capital-change-brief"
Use Arkolith's capital_change_brief for BlossomHill Therapeutics, Inc.. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for BLSM. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.